SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.81-4.2%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert S. who wrote (6682)7/15/1998 2:37:00 AM
From: Tharos  Read Replies (2) of 17367
 
>>What am I missing?<<

-----------------------------------------------------

In your enthusiasm to find an inconsistency in George's and my statements, how about you seem to be ignoring what I wrote. So, just for you, I broke out my crayon set to recompose:

Some bacteria are composed of lipopolysaccharide.
As long as the bacteria are composed of lipopolysaccharide,
BPI will bind to the bacteria's lipopolysaccharide,
and even if BPI does not kill the bacteria that are composed of lipopolysaccharide,
it will neutralize the lipopolysaccharide endotoxins caused by the bacteria's death,
that is to say, the bacteria made of lipopolysaccharide that die and give off lipopolysaccharide endotoxins.
Not all bacteria are composed of lipopolysaccharide,
Not all endotoxins are composed of lipopolysaccharide,
not all endotoxins come from bacteria,
so George is correct that BPI does not bind up all endotoxin.

I'm looking forward to your post with detailed analysis of all gram-negative bacteria and their genetic make-up.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext